Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-02-25 @ 6:59 PM
Study NCT ID:
NCT02014051
Status:
COMPLETED
Last Update Posted:
2022-11-21
First Post:
2013-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
Sponsor:
SymBio Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2012002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None